Cardiac imaging is an integral part of the evaluation and management of patients with known or suspected coronary artery disease (CAD). Significant advances in myocardial perfusion imaging (MPI) over the past decade have helped to increase clinical applications and improve diagnostic accuracy. It is important that the healthcare community plays a significant role in critically evaluating the use of MPI and effectively integrating and utilizing MPI in daily practice.
The Heart and Hospital Medicine is an initiative authored and supported by Astellas Pharma US, Inc. It includes a series of e-newsletters with timely and helpful information about cardiac imaging. To view the e-newsletters, click on the links below:
To further help clinicians determine whether cardiac radionuclide imaging (RNI) is appropriate, a smartphone application is available to help guide you through the decision-making process based on a set of published Appropriate Use Criteria (AUC).
By answering questions about your patient, you will see on a scale of 1-9 if the patient indication is appropriate (7-9), uncertain (4-6), or inappropriate (1-3), per the criteria. This user-friendly application is complimentary. Click here to find out how to download the AUC app to your smartphone or access the online version.
The Hospitalist newsmagazine reports on issues and trends in hospital medicine. The Hospitalist reaches more than 25,000 hospitalists, physician assistants, nurse practitioners, residents, and medical administrators interested in the practice and business of hospital medicine.